Top Markets
#1 MiL.k Alliance MiL.k Alliance +34.49%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.30%
#3 Biconomy Biconomy +20.08%
#4 Glidr Glidr +19.56%
#5 THORChain THORChain +18.25%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +15.96%
#7 Moolah Moolah +14.63%
#8 Tokamak Network Tokamak Network +14.19%
#9 THORChain Yield THORChain Yield +13.55%
#10 Tutorial Tutorial +12.80%
Coin of the day
MiL.k Alliance MiL.k Alliance
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

300255
Rang in Aktien #4854
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. operates within China,... Hebei Changshan Biochemical Pharmaceutical Co., Ltd. operates within China, focusing on the entire lifecycle of heparin-based pharmaceuticals – from their initial research and development to manufacturing and sales. Their products are primarily utilized for the treatment of cardiovascular and cerebrovascular diseases. The company offers a broad range of heparin compounds, including crude heparin sodium and refined heparin sodium raw materials. Their portfolio also features a variety of injectable heparin preparations, such as standard heparin sodium injections. Furthermore, they produce both the raw materials and finished injectable forms for several low molecular weight heparins, specifically low molecular weight heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium. Established in the year 2000, Hebei Changshan Biochemical Pharmaceutical Co., Ltd. is headquartered in Shijiazhuang, China.
Aktienkurs
$3.55
Marktkapitalisierung
$3.27B
Veränderung (1 Tag)
2.68%
Veränderung (1 Jahr)
-50.04%
Land
CN
Handel Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255)

Kategorie

Healthcare
Aktien-Split-Historie für Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255)
Die Aktie Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (Symbol: 300255) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 27, 2026 statt.
Eine 300255-Aktie, die vor dem Aug 27, 2026 gekauft wurde, entspricht heute 0 300255-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH